£90.22

Cancer Facts Press Transition from Crime to Care in Oncology: A Critical Review of Current Cancer Research and Its Applications

Price data last checked 97 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

Same price for 26 weeks. Today is much like next week.

£90 for 184 days straight · last change was Aug 2025

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 472 days • 472 data points (No recent data available)

Historical
Generating forecast...
£181.75 £76.19 £99.22 £122.25 £145.29 £168.32 £191.35 01 November 2024 26 February 2025 24 June 2025 20 October 2025 15 February 2026

Price Distribution

Price distribution over 472 days • 7 price levels

Days at Price
Current Price
57 days 184 days · current 215 days 9 days 1 day 4 days 2 days 0 54 108 161 215 £86 £90 £94 £99 £107 £133 £182 Days at Price

Price Analysis

Most common price: £94 (215 days, 45.6%)

Price range: £86 - £182

Price levels: 7 different prices over 472 days

Description

Cancer is widely regarded as the most challenging disease of our time. Conventional treatments and therapies generally address its symptoms, not the causes, which is why they largely prove ineffective. In his thought-provoking work, Transition from Crime to Care in Oncology, Dr. Mohammad A. Nezami-who has over a quarter of a century of experience conducting cutting-edge research treating this pernicious disease-shares his critical view on the current standard of care and colluded oncology research. He presents an eye-opening new understanding of cancer stem cell biology in concert with his "least toxic and most effective" approach to treatment. Dr. Nezami collaborates with major academic institutions and regulatory agencies while serving as a strong advocate of patients' rights of choice when it comes to treatment of terminal disease. Insightful and revelatory, Dr. Nezami's groundbreaking work signals an enlightening and exciting new direction for the field of oncology.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
01 August 2022
Listed Since
19 July 2022

Barcode

No barcode data available